Logozzi et al.24 recently showed that PCa patients had a four-fold more nanovesicles expressing both CD81 and PSA from plasma compared to BPH patients and healthy controls by quantifying their levels using nanoscale FCM and ELISA. Here, CD81 is linked to benign prostatic hyperplasia.